Trial Start Date : 2008-01-28 Trial Completion Date : 2010-09-01 (estimated)
Date Submitted to PDQ : 2003-08-14
Information Last Verified : 2010-04-10
Title :Ecteinascidin 743 in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
Basic Trial Information :
Phase : Phase II .
Type : Biomarker/Laboratory analysis , Treatment .
Status : Closed .
Age : 1 To 21 (at time of diagnosis).
Sponsor : NCI
Protocol IDs : COG-ADVL0221 NCT00070109, ADVL0221
Registry Information :
Official Title A Phase II Study Of Trabectedin (ET-743, Yondelis®) in Children With Recurrent Rhabdomyosarcoma, Ewing Sarcoma, or Nonrhabdomyosarcomatous Soft Tissue Sarcoma .
Registered in ClinicalTrials.gov NCT00070109
NCI Grant/Contract Number CA98543
.